GRDNHealthcareSmall-Cap

Guardian Pharmacy Services, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Guardian Pharmacy Services, Inc. (GRDN), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are GRDN insiders buying or selling?

Guardian Pharmacy Services, Inc. insiders reported 6 open-market buys ($948.3K) and 18 sells ($757.8M) across 24 Form 4 filings — a net selling position of $756.8M.

Source: SEC EDGAR Form 4

Key Statistics (as of Mar 24, 2026)

Total Form 4 filings
24
SEC EDGAR
Insider filers
12
Insider buys (6)
$948.3K
Insider sells (18)
$757.8M

Insider sentiment

Net selling

Net insider flow of $756.8M in net selling.

Recent GRDN insider transactions

DateInsiderRoleTypeSharesPriceValue
Mar 24, 2026Pharmacy Investors, LLCOtherSale827.6K$29.68$24.6M
Mar 24, 2026David K MorrisExecutive Vice President and Chief Financial OfficerSale187.9K$29.68$5.6M
Mar 24, 2026Fred BurkePresident and Chief Executive OfficerSale671.4K$29.68$19.9M
Mar 24, 2026Kendall ForbesExecutive Vice President, Sales & OperationsSale346.7K$29.68$10.3M
Mar 24, 2026Cardinal Equity Fund, L.P.OtherSale275.7K$29.68$8.2M
Mar 24, 2026Thomas J Salentine JrDirector, 10% OwnerSale3.6M$29.68$106.0M
Mar 24, 2026Bindley Capital Partners I, LLC10% OwnerSale3.6M$29.68$106.0M
Mar 24, 2026John AckermanDirectorSale1.1M$29.68$32.8M
Mar 24, 2026BINDLEY WILLIAM EDirector, 10% OwnerSale3.6M$29.68$106.0M
Dec 5, 2025Steven D CoslerDirectorPurchase3.4K$29.61$99.8K
Sep 30, 2025Cardinal Equity Fund, L.P.OtherSale321.3K$20.16$6.5M
Sep 30, 2025Pharmacy Investors, LLCOtherSale964.3K$20.16$19.4M
May 29, 2025BINDLEY WILLIAM EDirector, 10% OwnerSale4.2M$20.16$83.9M
May 29, 2025Thomas J Salentine JrDirector, 10% OwnerSale4.2M$20.16$83.9M
May 29, 2025John AckermanDirectorSale1.3M$20.16$25.9M
May 29, 2025David K MorrisExecutive Vice President and Chief Financial OfficerSale437.8K$20.16$8.8M
May 29, 2025Fred BurkePresident and Chief Executive OfficerSale885.8K$20.16$17.9M
May 29, 2025Kendall ForbesExecutive Vice President, Sales & OperationsSale415.0K$20.16$8.4M
May 29, 2025Bindley Capital Partners I, LLC10% OwnerSale4.2M$20.16$83.9M
Nov 20, 2024Steven D CoslerDirectorPurchase7.0K$21.22$148.5K
Oct 1, 2024Thomas J Salentine JrDirectorPurchase35.7K$14.00$500.0K
Oct 1, 2024Mary Sue PatchettDirectorPurchase3.6K$14.00$50.0K
Oct 1, 2024Randall J LewisDirectorPurchase3.6K$14.00$50.0K
Oct 1, 2024Steven D CoslerDirectorPurchase7.1K$14.00$100.0K

Showing the 24 most recent of 24 Form 4 filings for Guardian Pharmacy Services, Inc..

Most active GRDN insiders

  • Steven D Cosler3 filings
  • Thomas J Salentine Jr3 filings
  • Bindley Capital Partners I, LLC2 filings
  • BINDLEY WILLIAM E2 filings
  • Cardinal Equity Fund, L.P.2 filings

Ask anything about GRDN insider activity

Use Trabud's AI agent to query Guardian Pharmacy Services, Inc.'s Form 4 history in plain English — "Show me GRDN CEO purchases this year" or compare it against any other ticker.

Open the AI agent

GRDN insider trading FAQ

Are Guardian Pharmacy Services, Inc. insiders buying or selling?

Across 24 SEC Form 4 filings, Guardian Pharmacy Services, Inc. (GRDN) insiders reported 6 open-market purchases totaling $948.3K and 18 sales totaling $757.8M. That is a net selling position of $756.8M.

How many insiders trade GRDN stock?

12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Guardian Pharmacy Services, Inc.. The most recent filing was accepted on Mar 24, 2026.

Where does Trabud get GRDN insider trading data?

All GRDN insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content